Chemoinformaics analysis of E,E,Z-1,3,12-NONADECATRIENE-5,14-DIOL
Molecular Weight | 294.479 | nRot | 14 |
Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
Exact Molecular Weight | 294.256 | nRing | 0 |
Solubility: LogS | -3.44 | nHRing | 0 |
Solubility: LogP | 5.019 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 56.005 |
nHD | 2 | BPOL | 34.109 |
QED | 0.271 |
Synth | 3.49 |
Natural Product Likeliness | 1.891 |
NR-PPAR-gamma | 0.459 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.162 |
HIA | 0.114 |
CACO-2 | -4.752 |
MDCK | 0.0000265 |
BBB | 0.874 |
PPB | 0.950574 |
VDSS | 1.475 |
FU | 0.0270716 |
CYP1A2-inh | 0.133 |
CYP1A2-sub | 0.422 |
CYP2c19-inh | 0.119 |
CYP2c19-sub | 0.433 |
CYP2c9-inh | 0.15 |
CYP2c9-sub | 0.954 |
CYP2d6-inh | 0.03 |
CYP2d6-sub | 0.316 |
CYP3a4-inh | 0.292 |
CYP3a4-sub | 0.177 |
CL | 8.132 |
T12 | 0.265 |
hERG | 0.009 |
Ames | 0.139 |
ROA | 0.064 |
SkinSen | 0.962 |
Carcinogencity | 0.567 |
EI | 0.88 |
Respiratory | 0.944 |
NR-Aromatase | 0.381 |
Antiviral | No |
Prediction | 0.56646 |